Lifeline Biotechnologies, the medical technology company has licensed a “smart bra” known as First Warning Systems that could help women discover if they have bosom cancer. The company says it is capable not only of identifying bosom tissue abnormalities
at their earliest stages, but can also identify the general location of
such abnormalities in three dimensions to each of the four quadrants
of each bosom.
The bra is based on a novel bosom health screening device and method and could become available in Europe in 2013 and then in the United States of America in 2014, at US$ 1,000 (N160,000) for a pair.
Preliminary studies with the novel bra conducted in more than 650 women, resulted in an average detection of at least 90 percent. Compared with the standard mammogram, the tests averaged 70 percent accuracy.
Experts say while the bra is not intended as an additional step in the bosom cancer screening process, it could be an accurate identifier of early bosom abnormalities which generate heat via the presence of new blood vessels that nourish the area in question,” they noted.
The bra is based on a novel bosom health screening device and method and could become available in Europe in 2013 and then in the United States of America in 2014, at US$ 1,000 (N160,000) for a pair.
Preliminary studies with the novel bra conducted in more than 650 women, resulted in an average detection of at least 90 percent. Compared with the standard mammogram, the tests averaged 70 percent accuracy.
Experts say while the bra is not intended as an additional step in the bosom cancer screening process, it could be an accurate identifier of early bosom abnormalities which generate heat via the presence of new blood vessels that nourish the area in question,” they noted.
Facebook Comments Plugin Enhanced by Trendy Naija

No comments:
Post a Comment
Let us know your view on this post, kindly write your comment